Home › Leverkanker (hepatocellulair carcinoom) › Texas › Houston
Leverkanker (hepatocellulair carcinoom) klinische studies in Houston, TX
31 studies voor Leverkanker (hepatocellulair carcinoom) zoeken deelnemers op locaties in en rond Houston (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study of ZW251 in Participants With Advanced Solid Tumors
RekruterenFase 1
- MD Anderson Cancer Center, Houston
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
RekruterenFase 1/2
- Research Facility, Houston
National Liver Cancer Screening Trial
RekruterenFase 4
- Baylor College of Medicine, Houston
A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- The University of Texas Md Anderson Cancer Center, Houston
Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer
RekruterenFase 1/2
- M D Anderson Cancer Center, Houston
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
RekruterenFase 3
- Research Site, Houston
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RekruterenFase 1/2
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
RekruterenFase 1/2
- Research Site, Houston
A Study of MGC026 in Participants With Advanced Solid Tumors
RekruterenFase 1
- The University of Texas MD Anderson Cancer Center, Houston
- University of Texas Health Science Center at Houston, Houston
IDOV-Immune for Advanced Solid Tumors
RekruterenFase 1
- MD Anderson Cancer Center, Houston
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RekruterenFase 2
- University of Texas MD Anderson Cancer Center, Houston
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RekruterenFase 1
- The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services, Houston
- The University of Texas MD Anderson Cancer Center, Houston
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
RekruterenFase 1
- M D Anderson Cancer Center, Houston
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
RekruterenFase 1
- Clinical Trial Site, Houston
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Rekruteren
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma
RekruterenFase 1
- The University of Texas M. D. Anderson Cancer Center, Houston
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
RekruterenFase 1
- The University of Texas MD Anderson Cancer Center, Houston
Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy
RekruterenFase 2
- M D Anderson Cancer Center, Houston
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
Rekruteren
- M D Anderson Cancer Center, Houston
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
RekruterenFase 2
- USA12-0, Houston
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
RekruterenFase 1/2
- University of Texas MD Anderson Cancer Center, Houston
Impact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis Guidelines
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- M D Anderson Cancer Center, Houston
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
RekruterenFase 1/2
- MD Anderson Cancer Center, Houston
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
RekruterenFase 2
- Houston Methodist Hospital Cancer Center, Houston
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
RekruterenFase 1
- Oncology Consultants, Houston
Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
RekruterenFase 2
- Baylor College of Medicine, Houston
Zanzalintinib (XL-092) Plus Durvalumab and Tremelimumab in Unresectable Hepatocellular Carcinoma (ZENOBIA)
RekruterenFase 2
- Houston Methodist Neal Cancer Center, Houston
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
RekruterenFase 1
- Houston Methodist Hospital, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Houston
Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria
RekruterenFase 4
- Houston Methodist Research Institute, Houston
Leverkanker (hepatocellulair carcinoom) studies in andere steden
- New York City, NY24 studies
- Dallas, TX19 studies
- Los Angeles, CA19 studies
- Boston, MA18 studies
- Cleveland, OH18 studies
- Chicago, IL16 studies
- Philadelphia, PA16 studies
- Pittsburgh, PA15 studies
- San Francisco, CA14 studies
- Orange, CA14 studies
- Jacksonville, FL14 studies
- San Antonio, TX13 studies
Andere studies in Houston
- Niet-kleincellige longkanker145 studies
- Borstkanker126 studies
- Kanker (alle vormen)121 studies
- Metastatische kanker104 studies
- Colorectale kanker102 studies
- Eierstokkanker89 studies
- Acute myeloïde leukemie85 studies
- Longkanker78 studies
- Prostaatkanker76 studies
- Endometriumkanker68 studies
- Aldermeesklierkanker61 studies
- Melanoom59 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.